Denali Therapeutics Inc. Annual Current State and Local Tax Expense (Benefit) in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Denali Therapeutics Inc. annual Current State and Local Tax Expense (Benefit) history and growth rate from 2019 to 2023.
  • Denali Therapeutics Inc. annual Current State and Local Tax Expense (Benefit) for 2023 was $0.000, a 100% decline from 2022.
  • Denali Therapeutics Inc. annual Current State and Local Tax Expense (Benefit) for 2022 was $7K.
  • Denali Therapeutics Inc. annual Current State and Local Tax Expense (Benefit) for 2021 was -$576K, a 170% decline from 2020.
Current State and Local Tax Expense (Benefit), Annual (USD)
Current State and Local Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $0 -$7K -100% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 $7K +$583K Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 -$576K -$1.4M -170% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 $823K +$823K Jan 1, 2020 Dec 31, 2020 10-K 2023-02-27
2019 $0 Jan 1, 2019 Dec 31, 2019 10-K 2021-02-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.